Employer with a benefit plan ยท SEC filer
KALVISTA PHARMACEUTICALS, INC.
Also filed as Carbylan Biosurgery, Inc; Carbylan Therapeutics, Inc.
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA 02142
EIN
20-0915291
SEC CIK
0001348911
SEC · 2026-08-14
Industry (SIC)
Pharmaceutical Preparations (2834)
SEC · 2026-08-14
State of incorporation
DE
SEC · 2026-08-14
Latest SEC filing
SCHEDULE 13G/A 2026-08-14
SEC · 2026-08-14
Benefit plan 1, 2024 filing
KALVISTA PHARMACEUTICALS, INC. 401(K) PLAN
DOL · 2025-07-16
Participants (start of year)
64
DOL · 2025-07-16
Plan assets (end of year)
$9,509,655
DOL · 2025-07-16
Plan features
code 2E2F2G2J2K2T3D
DOL · 2025-07-16
Plan type
Multiemployer plan
DOL · 2025-07-16
Business code (NAICS)
325410
DOL · 2025-07-16
Benefit plan 1, 2023 filing
KALVISTA PHARMACEUTICALS, INC. 401(K) PLAN
DOL · 2024-07-18
Participants (start of year)
60
DOL · 2024-07-18
Plan assets (end of year)
$5,960,118
DOL · 2024-07-18
Plan features
code 2A2E2F2G2J2K2T3D
DOL · 2024-07-18